Patents by Inventor Sanjeev Kulkarni

Sanjeev Kulkarni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted chiral allosteric hemoglobin modifiers
    Publication number: 20050154062
    Abstract: A family of substituted chiral allosteric effectors of hemoglobin is useful for delivering more oxygen to hypoxic and ischemic tissues by reducing the oxygen affinity of hemoglobin in whole blood.
    Type: Application
    Filed: November 17, 2004
    Publication date: July 14, 2005
    Inventors: Donald Abraham, Gajanan Joshi, Stephen Hoffman, Melissa Grella, Richmond Danso-Danquah, Amal Youssef, Martin Safo, Sanjeev Kulkarni
  • Substituted chiral allosteric hemoglobin modifiers
    Patent number: 6894185
    Abstract: A family of substituted chiral allosteric effectors of hemoglobin is useful for delivering more oxygen to hypoxic and ischemic tissues by reducing the oxygen affinity of hemoglobin in whole blood.
    Type: Grant
    Filed: September 10, 2002
    Date of Patent: May 17, 2005
    Assignee: Allós Therapeutics, Inc.
    Inventors: Donald J. Abraham, Gajanan S. Joshi, Stephen J. Hoffman, Melissa Grella, Richmond Danso-Danquah, Amal Yousseff, Martin Safo, Sanjeev Kulkarni
  • Inhibitors of cyclin-dependent kinases and their use
    Publication number: 20040106581
    Abstract: The present invention relates to novel compounds for the inhibition of cyclin-dependent kinases, and more particularly, to chromenone derivatives of formula (Ia), 1
    Type: Application
    Filed: July 1, 2003
    Publication date: June 3, 2004
    Inventors: Bansi Lal, Kalpana Joshi, Sanjeev Kulkarni, Malcolm Mascarenhas, Shrikant Kamble, Maggie Joyce Rathos, Rajendrakumar Joshi
  • Substituted chiral allosteric hemoglobin modifiers
    Publication number: 20030130523
    Abstract: A family of substituted chiral allosteric effectors of hemoglobin is useful for delivering more oxygen to hypoxic and ischemic tissues by reducing the oxygen affinity of hemoglobin in whole blood.
    Type: Application
    Filed: September 10, 2002
    Publication date: July 10, 2003
    Inventors: Donald J. Abraham, Gajanan S. Joshi, Stephen J. Hoffman, Melissa Grella, Richmond Danso-Danquah, Amal Yousseff, Martin Safo, Sanjeev Kulkarni
  • Substituted chiral allosteric hemoglobin modifiers
    Patent number: 6486342
    Abstract: A family of substituted chiral allosteric effectors of hemoglobin is useful for delivering more oxygen to hypoxic and ischemic tissues by reducing the oxygen affinity of hemoglobin in whole blood.
    Type: Grant
    Filed: August 23, 2000
    Date of Patent: November 26, 2002
    Assignee: Virginia Commonwealth University
    Inventors: Donald J. Abraham, Gajanan S. Joshi, Stephen J. Hoffman, Melissa Grella, Richmond Danso-Danquah, Amal Yousseff, Martin Safo, Sanjeev Kulkarni